-+ 0.00%
-+ 0.00%
-+ 0.00%

Foghorn Therapeutics FY 2025 collaboration revenues rise 37% to USD 30.9 million, net loss narrows 14% to USD 74.3 million

Reuters·03/11/2026 20:21:21

Please log in to view news